Obstructive lung disease

Related records

Broader conditions (6)

• Disease
• Disease by body system or component
• Human disease
• Lower respiratory tract disorder
• Lung disorder
• Respiratory system disorder

Narrower conditions (15)

• Bronchiectasis
• Bronchiectasis with or without elevated sweat chloride 1
• Bronchiectasis with or without elevated sweat chloride 2
• Bronchiectasis with or without elevated sweat chloride 3
• Chronic bronchitis
• Chronic obstructive pulmonary disease
• Compensatory emphysema
• Congenital lobar emphysema
• COPD, severe early onset
• Diffuse panbronchiolitis
• Emphysema, hereditary pulmonary
• Hyperlucent lung
• Idiopathic bronchiectasis
• Interstitial emphysema
• Pulmonary emphysema

Trials (355)

• 26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
• A Cohort of Patients With Chronic Pulmonary Disease
• A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
• A Modified Cuff Leak Test and Reintubation in Mechanically Ventilated Patients
• A New Flexible Extended-Length Pharyngeal Airway for Deep Sedation
• A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
• A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
• A Phase I Study of iPS Cell Generation From Patients With COPD
• A Population-based Investigation of Asthma in the Telemark Region of Norway
• A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA
• A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
• A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
• A Study of Laryngoscopic Vision With the TotalTrack Device Versus Indirect Laryngoscopy
• A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD
• A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% in Participants With Alpha1-Antitrypsin Deficiency
• A Study to Evaluate the Diagnostic Performance of Portable Oscillometry Across Chronic Respiratory Diseases
• A Study to Evaluate the Effect of Yoga Exercises and Meditation on Lung Function and Quality of Life in COPD Patients.
• A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
• A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Approved drugs (55)

• Acefylline piperazine
• Aclidinium bromide
• Albuterol
• Aminophylline
• Amlexanox
• Beclomethasone dipropionate
• Benralizumab
• Betamethasone
• Bitolterol
• Budesonide
• Ciclesonide
• Clenbuterol
• Cromolyn
• Dyphylline
• Epinephrine
• Fenoterol
• Fenspiride
• Flunisolide
• Fluticasone furoate
• Fluticasone propionate

Drugs in development (14)

• AZD3199 Phase 2
• Bambuterol Phase 3
• Bamifylline Phase 2
• Carbuterol Phase 2
• Dexamethasone Phase 2
• Doxofylline Phase 3
• Eprozinol Phase 2
• Etamiphyllin Phase 2
• Hexoprenaline Phase 2
• Metaproterenol polistirex Phase 2
• Procaterol Phase 3
• Sodium iodide I 125 Phase 2
• Theobromine Phase 3
• Tretoquinol Phase 2